ERBB2 and neoplasm: Forexample, anti-Her2-sialidase conjugates88,89 were usedto selectively drive antitumor immune responses via the sialic acid-bindingimmunoglobulin-type lectin (Siglec)-E that is present on tumor-infiltratingmyeloid cells.